Masayuki Miyasaka

Title: The Innovations of Masayuki Miyasaka

Introduction

Masayuki Miyasaka is a notable inventor based in Urawa, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant protein receptors. With a total of 2 patents to his name, Miyasaka's work has the potential to impact various therapeutic applications.

Latest Patents

Miyasaka's latest patents include groundbreaking inventions related to recombinant protein receptors for interleukin-2 (IL-2). The first patent focuses on the recombinant IL-21R.beta. chain, which includes cDNA coding, vectors containing this cDNA, and monoclonal antibodies to the recombinant IL-2R.beta. or its fragments. The second patent pertains to the recombinant IL-2R.mu. protein, detailing similar components such as cDNA coding, vectors, and monoclonal antibodies to the encoded recombinant IL-2R.mu. protein or its fragments.

Career Highlights

Miyasaka is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research in biotechnology. His work is characterized by a commitment to innovation and a focus on developing solutions that can enhance therapeutic options for patients.

Collaborations

Miyasaka has collaborated with esteemed colleagues, including Takeshi Kono and Masanori Hatakeyama. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.

Conclusion

Masayuki Miyasaka's contributions to biotechnology through his patents on recombinant protein receptors for IL-2 highlight his innovative spirit and dedication to advancing medical science. His work at Boehringer Ingelheim International GmbH and collaborations with fellow researchers further underscore his impact in the field.